Search Results - "Prud'homme, GJ"

Refine Results
  1. 1

    DNA vaccination against tumors by Prud'homme, Gérald J.

    Published in The journal of gene medicine (01-01-2005)
    “…DNA vaccines have been used to generate protective immunity against tumors in a variety of experimental models. The favorite target antigens have been those…”
    Get full text
    Journal Article
  2. 2

    Clonal deletion and autoreactivity in extrathymic CD4-CD8-(double negative) T cell receptor-alpha/beta T cells by Prud'Homme, GJ, Bocarro, DC, Luke, EC

    Published in The Journal of immunology (1950) (15-11-1991)
    “…Peripheral CD4-CD8- (double negative) T cells (DNT cells) that express TCR-alpha/beta (DNT-alpha/beta cells) are expanded in some autoimmunity-prone mice, but…”
    Get full text
    Journal Article
  3. 3

    The Inhibitory Effects of Transforming Growth Factor-Beta-1 (TGF-β1) in Autoimmune Diseases by Prud'homme, Gérald J, Piccirillo, Ciriaco A

    Published in Journal of Autoimmunity (01-02-2000)
    “…The importance of transforming growth factor-beta-1 (TGF-β1) in immunoregulation and tolerance has been increasingly recognized. It is now proposed that there…”
    Get full text
    Book Review Journal Article
  4. 4

    Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report No. 10 by Rand, LI, Prud'homme, GJ, Ederer, F, Canner, PL

    “…Natural history data from the Diabetic Retinopathy Study were examined by multivariate methods to determine which baseline characteristics could predict the…”
    Get full text
    Journal Article
  5. 5

    Treatment of murine lupus with cDNA encoding IFN-γR/Fc by Lawson, Brian R., Prud’homme, Gerald J., Chang, Yigang, Gardner, Humphrey A., Kuan, Jason, Kono, Dwight H., Theofilopoulos, Argyrios N.

    Published in The Journal of clinical investigation (15-07-2000)
    “…IFN-γ, a pleiotropic cytokine, is a key effector molecule in the pathogenesis of several autoimmune diseases, including lupus. Importantly, deletion of IFN-γ…”
    Get full text
    Journal Article
  6. 6

    TGF- beta 1 Somatic Gene Therapy Prevents Autoimmune Disease in Nonobese Diabetic Mice by Piccirillo, CA, Chang, Y, Prud'homme, G J

    Published in The Journal of immunology (1950) (15-10-1998)
    “…Nonobese diabetic (NOD) mice develop insulitis and diabetes through an autoimmune process. Since TGF- beta 1 down-regulates many immune responses, we…”
    Get full text
    Journal Article
  7. 7

    Immunopathology and the gene therapy of lupus by Mageed, R A, Prud'homme, G J

    Published in Gene therapy (01-05-2003)
    “…Lupus is a chronic autoimmune inflammatory disease with complex clinical manifestations. In humans, lupus, also known as systemic lupus erythematosus (SLE),…”
    Get full text
    Journal Article
  8. 8

    Patterns of MHC antigenic modulation in cyclosporine-induced autoimmunity. Implications for pathogenesis by Parfrey, NA, Prud'homme, GJ

    Published in The American journal of pathology (01-02-1990)
    “…To explore the role of aberrant MHC expression in the pathogenesis of cyclosporine-induced autoimmunity (CSIA), we examined the patterns of major…”
    Get full text
    Journal Article
  9. 9

    The Phosphodiesterase Inhibitors Pentoxifylline and Rolipram Suppress Macrophage Activation and Nitric Oxide Production in Vitro and in Vivo by Beshay, Evette, Croze, France, Prud'homme, Gérald J.

    Published in Clinical immunology (Orlando, Fla.) (01-02-2001)
    “…We studied the effects of the phosphodiesterase inhibitors pentoxifylline (PTX) and rolipram (ROL) on nitric oxide (NO) production by macrophages and…”
    Get full text
    Journal Article
  10. 10

    Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors by Prud'homme, Gérald J.

    Published in The journal of gene medicine (01-07-2000)
    “…Gene therapy offers advantages for the immunotherapeutic delivery of cytokines or their inhibitors. After gene transfer, these mediators are produced at…”
    Get full text
    Journal Article
  11. 11

    Altering immune tolerance therapeutically: the power of negative thinking by Gérald J. Prud’homme

    Published in Journal of leukocyte biology (01-04-2004)
    “…The etiology of most human autoimmune diseases remains largely unknown. However, investigators have identified several negative regulatory mechanisms acting at…”
    Get full text
    Journal Article
  12. 12

    Plasmids encoding membrane-bound IL-4 or IL-12 strongly costimulate DNA vaccination against carcinoembryonic antigen (CEA) by Chakrabarti, Rabindranath, Chang, Yigang, Song, Keli, Prud’homme, Gerald J.

    Published in Vaccine (12-03-2004)
    “…Vaccination with plasmids encoding an antigen of interest (DNA vaccination) is a new strategy to achieve effective immunization against many agents. DNA…”
    Get full text
    Journal Article
  13. 13

    Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer by SONG, K, CHANG, Y, PRUD'HOMME, G. J

    Published in Gene therapy (01-03-2000)
    “…Intramuscular (i.m.) injections of a plasmid encoding human carcinoembryonic antigen (CEA) elicited both humoral and cellular immune responses in mice, but…”
    Get full text
    Journal Article
  14. 14

    Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand by Prud'homme, Gerald J, Chang, Yigang, Li, Xiaoying

    Published in Human gene therapy (10-02-2002)
    “…Cytotoxic T lymphocyte antigen 4 (CTLA-4 or CD152) is a strong negative regulator of T cell activity. Like CD28 (a positive regulator) it binds to B7-1 and…”
    Get more information
    Journal Article
  15. 15

    Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein by PRUD'HOMME, G. J, CHANG, Y

    Published in Gene therapy (01-05-1999)
    “…We report on long-term delivery of an interferon-gamma (IFN gamma) inhibitory protein by intramuscular (i.m.) gene therapy. IFN gamma is a cytokine that plays…”
    Get full text
    Journal Article
  16. 16

    Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes by Croze, France, Prud'homme, Gérald J.

    Published in The journal of gene medicine (01-05-2003)
    “…Background Despite improvements in insulin preparation and delivery, physiological normoglycemia is not easily achieved in diabetics. Therefore, there has been…”
    Get full text
    Journal Article
  17. 17

    Immunotherapeutic gene transfer into muscle by Prud'homme, Gérald J, Lawson, Brian R, Chang, Yigang, Theofilopoulos, Argyrios N

    Published in Trends in Immunology (01-03-2001)
    “…Immuno-gene therapy can be advantageously performed with nonviral approaches. Genes that encode regulatory cytokines or inflammatory cytokine inhibitors can be…”
    Get full text
    Book Review Journal Article
  18. 18

    IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice by Song, K, Chang, Y, Prud'homme, G J

    Published in Gene therapy (01-09-2000)
    “…Intramuscular (i.m.) injection of a plasmid encoding human carcinoembryonic antigen (CEA) elicited immunity against transplanted syngeneic (C57BL/6)…”
    Get full text
    Journal Article
  19. 19

    Intramuscular administration of expression plasmids encoding interferon-γ receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity by Chang, Yigang, Prud'homme, Gérald J.

    Published in The journal of gene medicine (01-11-1999)
    “…Background Interferon γ (IFNγ) is an inflammatory cytokine that promotes autoimmune insulitis and diabetes in NOD mice, while interleukin‐4 (IL‐4) is…”
    Get full text
    Journal Article
  20. 20

    GABAergic system in the endocrine pancreas: a new target for diabetes treatment by Wan, Yun, Wang, Qinghua, Prud'homme, Gerald J

    Published in Diabetes, metabolic syndrome and obesity (01-01-2015)
    “…Excessive loss of functional pancreatic β-cell mass, mainly due to apoptosis, is a major factor in the development of hyperglycemia in both type 1 and type 2…”
    Get full text
    Journal Article